Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zymeworks Inc
(NY:
ZYME
)
6.430
UNCHANGED
Last Price
Updated: 7:00 PM EST, Dec 15, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zymeworks Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
March 28, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
March 27, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Next-Gen Winners: 7 Tech Stocks Set to Dominate the Decade
March 08, 2024
Explore top tech stocks to dominate the decade, with their fundamental leading in information technology, finance, and health care.
Via
InvestorPlace
ZYME Stock Earnings: Zymeworks Beats EPS, Beats Revenue for Q4 2023
March 06, 2024
ZYME stock results show that Zymeworks beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
March 06, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
March 05, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
February 27, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Earnings Scheduled For March 6, 2024
March 06, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via
Benzinga
3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
February 22, 2024
Undervalued small-cap stocks are great for investors seeking options for upside potential, typically at a cheap share price.
Via
InvestorPlace
Last Call! 7 Small-Cap Stocks Ready to Explode in Value
February 20, 2024
Discover the small-cap stocks in the telecommunications, biotech, research, silver, transportation, and trading, ready to explode in value.
Via
InvestorPlace
Zymeworks - Analysts Project A Big Turnaround
February 20, 2024
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer.
Via
Talk Markets
7 Small-Cap Stocks With Significant Upside Potential in 2024
February 15, 2024
Dive into small-cap stocks for a mix of stability & growth, wagering on potential leaders before the market catches on.
Via
InvestorPlace
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
February 14, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial Officer
February 09, 2024
Via
Investor Brand Network
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
February 08, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
February 06, 2024
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.
Via
InvestorPlace
3 Top Stocks to Buy This Winter for Sizzling Summer Gains
January 31, 2024
With economic momentum accelerating, these three top stocks flying under Wall Street's radar seem poised for sizzling summer gains.
Via
InvestorPlace
Zymeworks Announces Participation in Upcoming Investor Conferences
January 31, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
A Look Into Healthcare Sector Value Stocks
January 22, 2024
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
January 15, 2024
Via
Benzinga
$10K to $100K: Small-Cap Marvels With Massive Upside
January 08, 2024
Transform $10K to $100K with top small-cap stocks. Discover market marvels with massive upside for savvy investors.
Via
InvestorPlace
Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025
January 04, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Additional Leadership Appointments
January 04, 2024
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
December 26, 2023
Proceeds expected to extend cash runway into H2 2027
From
Zymeworks Inc.
Via
GlobeNewswire
Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024
December 26, 2023
These three small-cap stocks have massive return potential in 2024 and beyond, according to analyst forecasts and broader industry trends.
Via
InvestorPlace
From $10k to $100k in 5 years: 3 Small-Cap Stocks to Make a Fortune
December 25, 2023
Are you looking for small-cap stocks to get rich? Turn $10k to $100k in 5 years in the stock market with these stocks.
Via
InvestorPlace
Want to Turn Spare Change Into $1,000? Buy These 3 Stocks Now
December 18, 2023
Three high conviction stocks seem perfect for opportunistic investors and could quickly transform spare change into four-figure returns.
Via
InvestorPlace
Zymeworks Added to Nasdaq Biotechnology Index
December 15, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Next Wave Biotech: 3 Stocks Poised for Breakthrough Success
December 13, 2023
The overall sector may be struggling after COVID, but there's still great potential in these three biotech stocks.
Via
InvestorPlace
Exposures
COVID-19
The 7 Best Bargain Growth Stocks to Buy Before 2024
December 11, 2023
These bargain growth stocks offer significant upside potential alongside decent margins of safety, for those seeking impressive value.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.